US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

RENOVARO BIOSCIENCES INC

0.2585

+0.00301.17%

Post-market: 0.2580-0.0005-0.19%19:52 EDT

Volume:578.46K

Turnover:148.07K

Market Cap:59.70M

PE:-0.68

High:0.2700

Open:0.2700

Low:0.2506

Close:0.2555

Loading ...

Overview Company News Filings

Renovaro Inc. Announces Date for Upcoming Special Meeting of Stockholders

Renovaro Inc. Expands AI Patent Portfolio with New Allowances to Strengthen Position in Biomedical Sector

Renovaro Inc - Maurice Van Tilburg Resigns as Chairman of Renovaro Inc. - SEC Filing

THOMSON REUTERS

Renovaro Inc. Announces Resignation of Chairman Maurice van Tilburg, Effective August 22, 2025

Renovaro Inc. Announces Date for Virtual Special Meeting of Stockholders

Renovaro BioSciences announces publication of study on dendritic cell therapy

Renovaro Inc. Announces Breakthrough Preclinical Study Validating Genetically Engineered Dendritic Cell Therapy for Pancreatic and Solid Tumors

Renovaro Inc. Faces Nasdaq Compliance Challenge Over Missed Shareholder Meeting Deadline

BRIEF-Renovaro Inc - Enters Exchange Agreement With Accredited Investors

Renovaro Inc. Announces New Shareholder Agreement to Exchange Secured Notes for Convertible Notes

Renovaro Inc. Announces New Patent Filing for AI-Based Neurotoxin Countermeasure Platform

Renovaro Inc. Announces CEO Transition: Maurice van Tilburg Steps Down from GEDi Cube B.V., Remains on Board of Directors

Renovaro's BioSymetrics Unit Gets Notice of Allowance for New Patent

MT Newswires Live

Renovaro Inc. Secures Key U.S. Patent to Enhance AI-Driven Drug Discovery and Diagnostics Platform

Sector Update: Health Care Stocks Retreat Thursday Afternoon

MT Newswires Live

Renovaro Gets Expedited Trial in Predictive Oncology Merger Dispute

MT Newswires Live

Renovaro announces expedited trial on suit to enforce Predictive Oncology merger

Renovaro Inc. Secures Expedited Trial for 2025 Lawsuit Against Predictive Oncology Over Alleged Merger Agreement Breach

Renovaro BioSciences, BioSymetrics close merger transaction

Press Release: Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/RENB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RENB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RENB\",,,,,undefined,":{"symbol":"RENB","market":"US","secType":"STK","nameCN":"RENOVARO BIOSCIENCES INC","latestPrice":0.2585,"timestamp":1754078400000,"preClose":0.2555,"halted":0,"volume":578460,"hourTrading":{"tag":"盘后","latestPrice":0.258,"preClose":0.2585,"latestTime":"19:52 EDT","volume":7938,"amount":2037.8183,"timestamp":1754092378686},"delay":0,"floatShares":150000000,"shares":230928963,"eps":-0.379223,"marketStatus":"Market Closed","change":0.003,"latestTime":"08-01 16:00:00 EDT","open":0.27,"high":0.27,"low":0.2506,"amount":148071.9752982,"amplitude":0.07593,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.379223,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754294400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.2555,"preHourTrading":{"tag":"盘前","latestPrice":0.269,"preClose":0.2555,"latestTime":"09:27 EDT","volume":15041,"amount":3884.27101673,"timestamp":1754054870149},"postHourTrading":{"tag":"盘后","latestPrice":0.258,"preClose":0.2585,"latestTime":"19:52 EDT","volume":7938,"amount":2037.8183,"timestamp":1754092378686},"volumeRatio":0.2958623159307571,"impliedVol":0.3452,"impliedVolPercentile":0.364},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RENB\",,,,,undefined,":{"symbol":"RENB","floatShares":150000000,"roa":"-8.41%","roe":"-53.17%","lyrEps":-0.83794,"volumeRatio":0.2958623159307571,"shares":230928963,"dividePrice":0,"high":0.27,"amplitude":0.07593,"preClose":0.2555,"low":0.2506,"week52Low":0.2506,"pbRate":"0.68","week52High":2.1,"institutionHeld":0,"latestPrice":0.2585,"eps":-0.379223,"divideRate":0,"volume":578460,"delay":0,"ttmEps":-0.379223,"open":0.27,"prevYearClose":0.8355,"prevWeekClose":0.3089,"prevMonthClose":0.2555,"prevQuarterClose":0.2889,"fiveDayClose":0.3089,"twentyDayClose":0.2889,"sixtyDayClose":0.2902},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RENB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2555259025","title":"Renovaro Inc. Announces Date for Upcoming Special Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2555259025","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555259025?lang=en_us&edition=fundamental","pubTime":"2025-07-31 01:09","pubTimestamp":1753895377,"startTime":"0","endTime":"0","summary":"Renovaro Inc. has announced a Special Meeting of Stockholders scheduled for August 15, 2025. The meeting will be held virtually via a live webcast. Among the matters to be addressed, stockholders will vote on Proposal 1. Renovaro Inc. has stated that no other matters are expected to be submitted for consideration at the Special Meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Renovaro Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 30, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250730:nNDL7VFS0q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RENB"],"gpt_icon":0},{"id":"2554077089","title":"Renovaro Inc. Expands AI Patent Portfolio with New Allowances to Strengthen Position in Biomedical Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2554077089","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554077089?lang=en_us&edition=fundamental","pubTime":"2025-07-28 22:38","pubTimestamp":1753713494,"startTime":"0","endTime":"0","summary":"Renovaro Inc. recently announced the allowance of multiple U.S. patents, a move that significantly bolsters its competitive stance in the biomedical artificial intelligence sector. Among these are innovations titled \"Methods, Systems, and Frameworks for Unbiased Data in Drug Discovery Predictions\" and \"Methods, Systems, and Frameworks for Federated Learning While Ensuring Bi-Directional Data Security.\" These patents address critical challenges in biomedical AI, such as data sparsity and source heterogeneity, and are expected to facilitate reproducible AI models in precision medicine. With a strategic focus on expanding its intellectual property in federated learning and AI-based data harmonization, Renovaro aims to solidify its position as a leader in next-generation biomedical research and precision medicine.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-ge","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nNDL4LQ3L3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RENB"],"gpt_icon":0},{"id":"2554792990","title":"Renovaro Inc - Maurice Van Tilburg Resigns as Chairman of Renovaro Inc. - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2554792990","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554792990?lang=en_us&edition=fundamental","pubTime":"2025-07-26 05:15","pubTimestamp":1753478132,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nFWN3TM1YG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RENB","BK4139"],"gpt_icon":0},{"id":"2554792956","title":"Renovaro Inc. Announces Resignation of Chairman Maurice van Tilburg, Effective August 22, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2554792956","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554792956?lang=en_us&edition=fundamental","pubTime":"2025-07-26 05:14","pubTimestamp":1753478060,"startTime":"0","endTime":"0","summary":"Renovaro Inc. announced that Maurice van Tilburg, Chairman of the Board of Directors, has resigned from his position effective August 22, 2025. His departure is due to his acceptance of a leadership role at another company in a different sector.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Renovaro Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 25, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nNDL99jNyF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RENB"],"gpt_icon":0},{"id":"2552649776","title":"Renovaro Inc. Announces Date for Virtual Special Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2552649776","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552649776?lang=en_us&edition=fundamental","pubTime":"2025-07-19 04:17","pubTimestamp":1752869830,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Renovaro Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 18, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250718:nNDL9xlfYt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RENB","BK4139"],"gpt_icon":0},{"id":"2552484091","title":"Renovaro BioSciences announces publication of study on dendritic cell therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2552484091","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552484091?lang=en_us&edition=fundamental","pubTime":"2025-07-17 21:30","pubTimestamp":1752759032,"startTime":"0","endTime":"0","summary":"Renovaro Biosciences (RENB) announced the publication of a peer-reviewed study in Vaccines. The paper details preclinical data on Renovaro’s next-g...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/renovaro-biosciences-announces-publication-of-study-on-dendritic-cell-therapy-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/renovaro-biosciences-announces-publication-of-study-on-dendritic-cell-therapy-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RENB"],"gpt_icon":0},{"id":"2552065481","title":"Renovaro Inc. Announces Breakthrough Preclinical Study Validating Genetically Engineered Dendritic Cell Therapy for Pancreatic and Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2552065481","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552065481?lang=en_us&edition=fundamental","pubTime":"2025-07-17 21:15","pubTimestamp":1752758121,"startTime":"0","endTime":"0","summary":"Renovaro Inc. Announces Breakthrough Preclinical Study Validating Genetically Engineered Dendritic Cell Therapy for Pancreatic and Solid Tumors. Renovaro Biosciences  has announced the publication of a peer-reviewed study in the journal Vaccines, showcasing preclinical data on its genetically engineered dendritic cell therapy platform. The study demonstrates the platform's ability to significantly reduce pancreatic tumor burden and activate robust immune responses in humanized mouse models. Key findings include a reduction in tumor weight and volume by up to 81.7%, increased immune cell activity, and selective cytotoxicity against pancreatic tumor cells. The platform's scalable, off-the-shelf approach uses CD34 hematopoietic stem cells, enhancing its clinical utility. Renovaro plans to initiate further preclinical studies across multiple tumor types and explore combination strategies with other therapies. The full study is available in Vaccines.Disclaimer: This news brief was created b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDL7Sqpb2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RENB","BK4139"],"gpt_icon":0},{"id":"2551181146","title":"Renovaro Inc. Faces Nasdaq Compliance Challenge Over Missed Shareholder Meeting Deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2551181146","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551181146?lang=en_us&edition=fundamental","pubTime":"2025-07-14 21:19","pubTimestamp":1752499155,"startTime":"0","endTime":"0","summary":"Renovaro Inc. has announced that it received a notice from Nasdaq, indicating non-compliance with Listing Rule 5620 due to not holding an annual meeting of shareholders within one year of the end of its fiscal year on June 30, 2024. The company has 45 days from the notice date, July 7, 2025, to submit a compliance plan to Nasdaq. If accepted, Renovaro could receive an extension until December 29, 2025, to meet the requirement. The company is actively working on a compliance plan and intends to hold the annual meeting as soon as possible. This notice does not currently impact the listing or trading of Renovaro's stock on Nasdaq, but failure to comply may result in delisting.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250714:nNDL7Vd0pk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RENB"],"gpt_icon":0},{"id":"2550163519","title":"BRIEF-Renovaro Inc - Enters Exchange Agreement With Accredited Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2550163519","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550163519?lang=en_us&edition=fundamental","pubTime":"2025-07-09 18:03","pubTimestamp":1752055413,"startTime":"0","endTime":"0","summary":"BRIEF-Renovaro Inc - Enters Exchange Agreement With Accredited InvestorsJuly 9  - Renovaro Inc RENB.O:RENOVARO INC - ENTERS EXCHANGE AGREEMENT WITH ACCREDITED INVESTORS - SEC FILINGRENOVARO INC - INVESTORS EXCHANGE $9.7 MILLION SECURED NOTES FOR $16.1 MILLION CONVERTIBLE NOTES - SEC FILINGFurther company coverage: RENB.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nFWN3T60ER:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RENB","BK4139"],"gpt_icon":0},{"id":"2550635947","title":"Renovaro Inc. Announces New Shareholder Agreement to Exchange Secured Notes for Convertible Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2550635947","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550635947?lang=en_us&edition=fundamental","pubTime":"2025-07-09 18:01","pubTimestamp":1752055292,"startTime":"0","endTime":"0","summary":"Renovaro Inc., a Delaware-based corporation, has announced a new Exchange Agreement as of 2025. The agreement involves the exchange of secured promissory notes held by certain noteholders for unsecured convertible notes. This move is designed to induce the holders to swap their currently due and payable secured notes for new terms. The agreement, governed by Florida state law, was confirmed by Nathen Fuentes, the company's Chief Financial Officer. This strategic exchange aims to enhance the company's financial flexibility and improve its capital structure. Further details on the principal amounts and specific terms of the replacement notes remain undisclosed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Renovaro Inc. published the or","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nNDL35nD76:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RENB"],"gpt_icon":0},{"id":"2547013576","title":"Renovaro Inc. Announces New Patent Filing for AI-Based Neurotoxin Countermeasure Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2547013576","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547013576?lang=en_us&edition=fundamental","pubTime":"2025-06-30 23:00","pubTimestamp":1751295601,"startTime":"0","endTime":"0","summary":"Renovaro Inc. has announced the filing of a new patent application titled \"Methods, Systems, and Frameworks for Unbiased Data in Drug Discovery Predictions.\" This development strengthens the company's intellectual property portfolio, focusing on real-time, reproducible analytics across distributed computing environments. The patent application supports Renovaro's scalable drug discovery and diagnostics business by protecting its machine learning infrastructure for multi-modal biomedical data integration and predictive analytics.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Renovaro Inc. published the original content used to generate this news brief via ACCESS Newswire  on June 30, 2025, and is solely responsible for the information ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL54q5mn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RENB","BK4139"],"gpt_icon":0},{"id":"2541003719","title":"Renovaro Inc. Announces CEO Transition: Maurice van Tilburg Steps Down from GEDi Cube B.V., Remains on Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2541003719","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541003719?lang=en_us&edition=fundamental","pubTime":"2025-06-06 04:02","pubTimestamp":1749153750,"startTime":"0","endTime":"0","summary":"Renovaro Inc. announced that Maurice van Tilburg has resigned as the Chief Executive Officer of GEDi Cube B.V., a wholly-owned indirect subsidiary of the company, effective May 30, 2025. Despite stepping down from this position, Mr. van Tilburg will continue his role on the company's Board of Directors. His resignation was not due to any disagreements with the company or its board.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Renovaro Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDL4Hwzfl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RENB"],"gpt_icon":0},{"id":"2540703647","title":"Renovaro's BioSymetrics Unit Gets Notice of Allowance for New Patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2540703647","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540703647?lang=en_us&edition=fundamental","pubTime":"2025-06-03 22:22","pubTimestamp":1748960543,"startTime":"0","endTime":"0","summary":"Renovaro  said Tuesday that its BioSymetrics unit received a notice of allowance from the US Patent and Trademark Office for a new patent application.The patent protects novel methods for integrating and harmonizing diverse biomedical data sources in a framework for predictive modeling, according to Renovaro.Shares of the company jumped 8.8% in recent trading.Price: 0.33, Change: +0.04, Percent Change: +14.94","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RENB","BK4139"],"gpt_icon":0},{"id":"2540774725","title":"Renovaro Inc. Secures Key U.S. Patent to Enhance AI-Driven Drug Discovery and Diagnostics Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2540774725","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540774725?lang=en_us&edition=fundamental","pubTime":"2025-06-03 21:15","pubTimestamp":1748956511,"startTime":"0","endTime":"0","summary":"Renovaro Inc. has announced the receipt of a Notice of Allowance from the United States Patent and Trademark Office for a new patent application titled \"Methods, Systems, and Frameworks for Unbiased Data in Drug Discovery Predictions.\" This patent enhances Renovaro's intellectual property portfolio by securing methods for integrating and harmonizing diverse biomedical data sources into a standardized framework for predictive modeling. This strategic milestone strengthens their position in the data-driven therapeutics market, addressing challenges in pharmaceutical R&D by improving data integration and analytics. The patent also supports Renovaro's revenue growth strategy by protecting its technology approach, which is crucial for commercial partnerships and platform deployment in life sciences and healthcare.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-gen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL2GqRbs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4585","LU2210150020.SGD","LU2210149790.SGD","BK4588","IE00B3QW5Z07.USD","NDAQ","BK4139","IE00B64PRP62.GBP","RENB","LU2095319765.USD","BK4112","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2537373929","title":"Sector Update: Health Care Stocks Retreat Thursday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2537373929","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537373929?lang=en_us&edition=fundamental","pubTime":"2025-05-23 01:56","pubTimestamp":1747936573,"startTime":"0","endTime":"0","summary":"Health care stocks declined Thursday afternoon, with the NYSE Health Care Index down 0.7% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.6%.The iShares Biotechnology ETF (IBB) was fracti","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","LU2087621335.USD","LU1066051498.USD","DNA.AU","BK4007","BK4578","POAI","BK4505","IBB","DNA","LU1778281490.HKD","LU2089984988.USD","BK4568","SNY","LU1839511570.USD","IE0002270589.USD","LU0289739699.SGD","BK7078","IE00BZ1G4Q59.USD","HOOK","BK4585","LU1430594728.SGD","LU1571399168.USD","XLV","BK4566","BK4198","BK4109","BK4581","LU0109394709.USD","LU0823416689.USD","LU0889565916.HKD","RENB","LU0058720904.USD","VIGL","GILD","LU2468319806.SGD","BK4583","IE00B19Z3B42.SGD","IE00B3T34201.USD","IE00BSNM7G36.USD","LU1674673691.USD","BK4588","IE00B19Z3581.USD","IE00BFXG1179.USD","LU1066053197.SGD","LU1585245621.USD","BK4082","LU0234570918.USD","LU0320765992.SGD","BK4139"],"gpt_icon":0},{"id":"2537928045","title":"Renovaro Gets Expedited Trial in Predictive Oncology Merger Dispute","url":"https://stock-news.laohu8.com/highlight/detail?id=2537928045","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537928045?lang=en_us&edition=fundamental","pubTime":"2025-05-22 23:44","pubTimestamp":1747928644,"startTime":"0","endTime":"0","summary":"Renovaro  said Thursday it has received a court ruling to expedite a trial this year related to its lawsuit against Predictive Oncology , seeking to enforce a contested merger agreement between the two biotechnology firms.The case, filed May 9 in the Delaware Court of Chancery, centers on a binding letter agreement signed Jan. 1 under which Predictive Oncology would merge into Renovaro in exchange for a new class of preferred stock, the company said.Renovaro claims Predictive Oncology violated exclusivity and good faith terms by conducting a $545,000 securities offering on Feb. 19, allegedly in breach of the agreement, and then attempting to terminate the deal unilaterally in April without further negotiation, the company said, adding that the lawsuit seeks specific performance, injunctive relief, and damages.Renovaro shares were up 10.7% while Predictive shares were down 9.2% in recent trading.Price: 0.32, Change: +0.03, Percent Change: +10.58","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["POAI","BK4139","BK4198","RENB","BK4082"],"gpt_icon":0},{"id":"2537928921","title":"Renovaro announces expedited trial on suit to enforce Predictive Oncology merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2537928921","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537928921?lang=en_us&edition=fundamental","pubTime":"2025-05-22 23:10","pubTimestamp":1747926621,"startTime":"0","endTime":"0","summary":"Renovaro (RENB) has received a ruling to expedite a trial in 2025 for the lawsuit it filed on May 9, in the Delaware Court of Chancery against Pred...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/renovaro-announces-expedited-trial-on-suit-to-enforce-predictive-oncology-merger-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/renovaro-announces-expedited-trial-on-suit-to-enforce-predictive-oncology-merger-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RENB","BK4082","BK4139","BK4198","POAI"],"gpt_icon":0},{"id":"2537940748","title":"Renovaro Inc. Secures Expedited Trial for 2025 Lawsuit Against Predictive Oncology Over Alleged Merger Agreement Breach","url":"https://stock-news.laohu8.com/highlight/detail?id=2537940748","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537940748?lang=en_us&edition=fundamental","pubTime":"2025-05-22 23:05","pubTimestamp":1747926314,"startTime":"0","endTime":"0","summary":"Renovaro Inc., a leader in TechBio specializing in diagnostics, drug discovery, and cancer therapies, has announced an expedited trial date in its lawsuit against Predictive Oncology Inc. The litigation, filed on May 9, 2025, in the Delaware Court of Chancery, seeks to enforce a binding merger agreement initially executed on January 1, 2025. Renovaro alleges that Predictive Oncology breached provisions of the agreement by conducting a public offering of $545,000 in securities and attempting to terminate the agreement unilaterally without meaningful negotiations. Renovaro is pursuing specific performance, injunctive relief, and damages, with the case currently pending under Case No. 2025-0509.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nNDL2fDD9X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BKPKM429.USD","LU2210150020.SGD","POAI","RENB","IE00B3QW5Z07.USD","BK4112","NDAQ","BK4198","BK4588","IE00BGHQF748.EUR","LU2095319765.USD","IE00B64PRP62.GBP","LU2210149790.SGD","BK4082","BK4585"],"gpt_icon":0},{"id":"2526362312","title":"Renovaro BioSciences, BioSymetrics close merger transaction","url":"https://stock-news.laohu8.com/highlight/detail?id=2526362312","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526362312?lang=en_us&edition=fundamental","pubTime":"2025-04-09 21:31","pubTimestamp":1744205500,"startTime":"0","endTime":"0","summary":"Renovaro Biosciences (RENB) closed its previously announced merger transaction with BioSymetrics on April 8. Renovaro’s merger with BioSymetrics is...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/renovaro-biosciences-biosymetrics-close-merger-transaction?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/renovaro-biosciences-biosymetrics-close-merger-transaction?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RENB"],"gpt_icon":0},{"id":"2526364693","title":"Press Release: Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2526364693","media":"Dow Jones","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526364693?lang=en_us&edition=fundamental","pubTime":"2025-04-09 21:25","pubTimestamp":1744205100,"startTime":"0","endTime":"0","summary":"Strategic Combination Intended to Drive Advanced AI-Driven Drug Development and Expand Precision Medicine Applications Across Cancer and Neurology. LOS ANGELES, April 09, 2025  -- Renovaro Biosciences Inc. , a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today announced it closed its previously announced merger transaction with BioSymetrics, an artificial intelligence -driven drug discovery and precision neurology company on April 8, 2025.Renovaro's merger with BioSymetrics is designed to enhance Renovaro's data repository and biomarker discovery capabilities, as well as add in vivo validation and drug discovery to Renovaro's AI powered biomarker and diagnostic platform.BioSymetrics' AI technology has been instrumental in uncovering novel disease signatures","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RENB","AAQC","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":36,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RENB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"RENB","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":0},{"market":"US","date":"2025-02-19","symbol":"RENB","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739941200000,"reportTimeType":"post","actualEps":-0.02},{"market":"US","date":"2024-11-14","symbol":"RENB","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2024-10-10","symbol":"RENB","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1728532800000,"reportTimeType":"post","actualEps":-0.45},{"market":"US","date":"2024-05-15","symbol":"RENB","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RENB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RENB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RENB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RENB","date":"2025-08-01","current":-0.996136,"percent":0.744186,"low":-11.254936,"twenty":-5.594214,"median":-1.619916,"eighty":-0.916862,"high":-0.425746,"avg":-3.182183,"sd":2.888137,"marketCap":59002350},"quantilePoints":[{"date":"2023-08-11","current":-0.842296,"twenty":-0.858231,"median":-0.663023,"eighty":-0.461441,"marketCap":89892200},{"date":"2023-08-18","current":-0.921973,"twenty":-0.901484,"median":-0.882134,"eighty":-0.681804,"marketCap":98395516},{"date":"2023-08-25","current":-1.38865,"twenty":-1.080188,"median":-0.904899,"eighty":-0.830914,"marketCap":148200654},{"date":"2023-09-01","current":-1.781342,"twenty":-1.390926,"median":-1.024414,"eighty":-0.866199,"marketCap":190109855},{"date":"2023-09-08","current":-1.838254,"twenty":-1.738089,"median":-1.138238,"eighty":-0.882134,"marketCap":196183652},{"date":"2023-09-15","current":-1.804107,"twenty":-1.831424,"median":-1.371576,"eighty":-0.88441,"marketCap":192539374},{"date":"2023-09-22","current":-2.191108,"twenty":-1.848498,"median":-1.479709,"eighty":-0.901484,"marketCap":233841196},{"date":"2023-09-29","current":-2.316314,"twenty":-1.946387,"median":-1.676055,"eighty":-0.933355,"marketCap":247203550},{"date":"2023-10-06","current":-7.118779,"twenty":-2.179726,"median":-1.781342,"eighty":-0.980023,"marketCap":282502019},{"date":"2023-10-13","current":-7.74788,"twenty":-5.197793,"median":-1.82118,"eighty":-1.031244,"marketCap":307467313},{"date":"2023-10-20","current":-5.711578,"twenty":-7.168445,"median":-1.855328,"eighty":-1.080188,"marketCap":226658596},{"date":"2023-10-27","current":-4.635484,"twenty":-7.135334,"median":-1.855328,"eighty":-1.118888,"marketCap":183954803},{"date":"2023-11-03","current":-5.049366,"twenty":-7.026069,"median":-1.943541,"eighty":-1.206532,"marketCap":200379339},{"date":"2023-11-10","current":-4.689234,"twenty":-6.615498,"median":-2.10574,"eighty":-1.302144,"marketCap":186087821},{"date":"2023-11-17","current":-4.561671,"twenty":-5.969841,"median":-2.191108,"eighty":-1.374991,"marketCap":187755275},{"date":"2023-11-24","current":-5.396221,"twenty":-5.585435,"median":-2.219564,"eighty":-1.390926,"marketCap":222104819},{"date":"2023-12-01","current":-5.396221,"twenty":-5.49345,"median":-4.524078,"eighty":-1.428488,"marketCap":222104819},{"date":"2023-12-08","current":-5.444836,"twenty":-5.444836,"median":-4.635484,"eighty":-1.545727,"marketCap":224105763},{"date":"2023-12-15","current":-5.720319,"twenty":-5.636053,"median":-4.686221,"eighty":-1.656136,"marketCap":235444448},{"date":"2023-12-22","current":-5.412426,"twenty":-5.636053,"median":-4.701705,"eighty":-1.675486,"marketCap":222771800},{"date":"2023-12-29","current":-5.169353,"twenty":-5.606885,"median":-4.76643,"eighty":-1.678901,"marketCap":212767079},{"date":"2024-01-05","current":-5.847089,"twenty":-5.626331,"median":-4.823692,"eighty":-1.699389,"marketCap":240662238},{"date":"2024-01-12","current":-7.088371,"twenty":-5.780749,"median":-4.953966,"eighty":-1.754024,"marketCap":291752546},{"date":"2024-01-19","current":-7.349693,"twenty":-6.206408,"median":-5.070988,"eighty":-1.790448,"marketCap":302508400},{"date":"2024-01-26","current":-7.962168,"twenty":-7.106616,"median":-5.169353,"eighty":-1.810936,"marketCap":327717433},{"date":"2024-02-02","current":-7.072038,"twenty":-7.137369,"median":-5.263632,"eighty":-1.82118,"marketCap":291080305},{"date":"2024-02-09","current":-5.896087,"twenty":-7.137369,"median":-5.347607,"eighty":-1.82801,"marketCap":242678961},{"date":"2024-02-16","current":-6.969,"twenty":-7.137369,"median":-5.363812,"eighty":-1.845084,"marketCap":287336744},{"date":"2024-02-23","current":-6.969,"twenty":-7.150435,"median":-5.387578,"eighty":-1.855328,"marketCap":287336744},{"date":"2024-03-01","current":-8.990011,"twenty":-7.198517,"median":-5.396221,"eighty":-1.861019,"marketCap":370664399},{"date":"2024-03-08","current":-10.418656,"twenty":-7.379651,"median":-5.404324,"eighty":-1.89289,"marketCap":429568432},{"date":"2024-03-15","current":-10.906486,"twenty":-7.477571,"median":-5.444836,"eighty":-1.935004,"marketCap":449682004},{"date":"2024-03-22","current":-10.244431,"twenty":-7.594683,"median":-5.466304,"eighty":-1.975981,"marketCap":422385013},{"date":"2024-03-28","current":-9.721756,"twenty":-7.6659,"median":-5.49345,"eighty":-2.048828,"marketCap":400834757},{"date":"2024-04-05","current":-9.721756,"twenty":-7.780991,"median":-5.585767,"eighty":-2.162652,"marketCap":400834757},{"date":"2024-04-12","current":-8.537025,"twenty":-7.909815,"median":-5.683539,"eighty":-2.162652,"marketCap":351987511},{"date":"2024-04-19","current":-8.01435,"twenty":-8.049195,"median":-5.736523,"eighty":-2.191108,"marketCap":330437255},{"date":"2024-04-26","current":-5.92365,"twenty":-8.01435,"median":-5.889227,"eighty":-2.196799,"marketCap":244236232},{"date":"2024-05-03","current":-5.191905,"twenty":-7.962168,"median":-5.736523,"eighty":-2.219564,"marketCap":214065874},{"date":"2024-05-10","current":-4.1814,"twenty":-7.909815,"median":-5.683539,"eighty":-2.316314,"marketCap":172402046},{"date":"2024-05-17","current":-2.443812,"twenty":-7.872338,"median":-5.585767,"eighty":-2.443812,"marketCap":131786997},{"date":"2024-05-24","current":-3.61057,"twenty":-7.790675,"median":-5.49948,"eighty":-2.523736,"marketCap":194706526},{"date":"2024-05-31","current":-4.020862,"twenty":-7.782928,"median":-5.490611,"eighty":-2.561678,"marketCap":216832267},{"date":"2024-06-07","current":-3.637923,"twenty":-7.780991,"median":-5.444836,"eighty":-2.581602,"marketCap":196181575},{"date":"2024-06-14","current":-3.966156,"twenty":-7.761124,"median":-5.43582,"eighty":-2.609206,"marketCap":213882168},{"date":"2024-06-21","current":-3.938803,"twenty":-7.742964,"median":-5.412426,"eighty":-2.63681,"marketCap":212407119},{"date":"2024-06-28","current":-4.10292,"twenty":-7.738048,"median":-5.396221,"eighty":-2.647751,"marketCap":221257416},{"date":"2024-07-05","current":-4.321743,"twenty":-7.714683,"median":-5.396221,"eighty":-2.94281,"marketCap":233057811},{"date":"2024-07-12","current":-3.966156,"twenty":-7.699226,"median":-5.387578,"eighty":-3.371454,"marketCap":213882168},{"date":"2024-07-15","current":-3.966156,"twenty":-7.69872,"median":-5.380016,"eighty":-3.449983,"marketCap":213882168},{"date":"2024-08-02","current":-1.91497,"twenty":-7.698214,"median":-5.371914,"eighty":-3.135869,"marketCap":103268211},{"date":"2024-08-09","current":-1.773009,"twenty":-7.6659,"median":-5.347607,"eighty":-2.571163,"marketCap":95612704},{"date":"2024-08-16","current":-1.858076,"twenty":-7.631055,"median":-5.298934,"eighty":-2.219564,"marketCap":100200108},{"date":"2024-08-23","current":-1.800361,"twenty":-7.615438,"median":-5.234173,"eighty":-2.162652,"marketCap":97087754},{"date":"2024-08-30","current":-1.096953,"twenty":-7.594683,"median":-5.191905,"eighty":-1.942322,"marketCap":96659989},{"date":"2024-09-06","current":-0.956172,"twenty":-7.594683,"median":-5.169353,"eighty":-1.883292,"marketCap":84254824},{"date":"2024-09-13","current":-1.039201,"twenty":-7.568029,"median":-5.122215,"eighty":-1.855328,"marketCap":91571069},{"date":"2024-09-20","current":-0.898922,"twenty":-7.561365,"median":-5.068368,"eighty":-1.82118,"marketCap":79210154},{"date":"2024-09-27","current":-0.801832,"twenty":-7.538402,"median":-4.941343,"eighty":-1.780605,"marketCap":70654868},{"date":"2024-10-04","current":-0.840501,"twenty":-7.499872,"median":-4.812365,"eighty":-1.72119,"marketCap":74062232},{"date":"2024-10-11","current":-0.852916,"twenty":-7.482618,"median":-4.731822,"eighty":-1.672382,"marketCap":68787798},{"date":"2024-10-18","current":-1.441668,"twenty":-7.469223,"median":-4.689234,"eighty":-1.611745,"marketCap":116270748},{"date":"2024-10-25","current":-0.987903,"twenty":-7.425307,"median":-4.683207,"eighty":-1.393203,"marketCap":79674514},{"date":"2024-10-31","current":-1.045809,"twenty":-7.406141,"median":-4.602373,"eighty":-1.33948,"marketCap":84344712},{"date":"2024-11-08","current":-1.091709,"twenty":-7.392372,"median":-4.486173,"eighty":-1.206786,"marketCap":88046508},{"date":"2024-11-15","current":-0.800809,"twenty":-7.364672,"median":-4.349095,"eighty":-1.204333,"marketCap":92643312},{"date":"2024-11-22","current":-0.687074,"twenty":-7.320294,"median":-4.29439,"eighty":-1.148518,"marketCap":79485644},{"date":"2024-11-29","current":-1.037745,"twenty":-7.274563,"median":-4.196865,"eighty":-1.139226,"marketCap":120053797},{"date":"2024-12-06","current":-1.975612,"twenty":-7.221841,"median":-4.130273,"eighty":-1.130296,"marketCap":228552972},{"date":"2024-12-13","current":-2.359759,"twenty":-7.19548,"median":-4.075567,"eighty":-1.139226,"marketCap":272993828},{"date":"2024-12-20","current":-2.119667,"twenty":-7.179834,"median":-4.020862,"eighty":-1.141284,"marketCap":245218293},{"date":"2024-12-27","current":-1.243675,"twenty":-7.166767,"median":-4.020862,"eighty":-1.14292,"marketCap":143877270},{"date":"2025-01-03","current":-1.046937,"twenty":-7.153701,"median":-3.966156,"eighty":-1.14215,"marketCap":121117203},{"date":"2025-01-10","current":-1.144209,"twenty":-7.140635,"median":-3.966156,"eighty":-1.143797,"marketCap":132370263},{"date":"2025-01-17","current":-1.028965,"twenty":-7.137369,"median":-3.938144,"eighty":-1.135591,"marketCap":119038006},{"date":"2025-01-24","current":-1.426831,"twenty":-7.127569,"median":-3.911451,"eighty":-1.121942,"marketCap":165066035},{"date":"2025-01-31","current":-1.049818,"twenty":-7.119682,"median":-3.884098,"eighty":-1.119209,"marketCap":121450510},{"date":"2025-02-07","current":-0.921952,"twenty":-7.100534,"median":-3.630902,"eighty":-1.092825,"marketCap":106658053},{"date":"2025-02-14","current":-1.017989,"twenty":-7.088371,"median":-3.528511,"eighty":-1.069204,"marketCap":117768267},{"date":"2025-02-21","current":-1.135052,"twenty":-7.081838,"median":-2.653222,"eighty":-1.076928,"marketCap":134401986},{"date":"2025-02-28","current":-1.347103,"twenty":-7.065505,"median":-2.598891,"eighty":-1.076928,"marketCap":159511096},{"date":"2025-03-07","current":-1.131299,"twenty":-7.048899,"median":-2.565552,"eighty":-1.088965,"marketCap":133957577},{"date":"2025-03-14","current":-1.060525,"twenty":-7.03869,"median":-2.436084,"eighty":-1.088965,"marketCap":125577293},{"date":"2025-03-21","current":-0.927155,"twenty":-7.03869,"median":-2.359759,"eighty":-1.067398,"marketCap":109784900},{"date":"2025-03-28","current":-0.870591,"twenty":-7.024371,"median":-2.291162,"eighty":-1.047047,"marketCap":103087022},{"date":"2025-04-04","current":-0.635556,"twenty":-6.989335,"median":-2.250002,"eighty":-1.040362,"marketCap":75256474},{"date":"2025-04-11","current":-0.49022,"twenty":-6.969,"median":-2.193954,"eighty":-1.037745,"marketCap":58047218},{"date":"2025-04-17","current":-0.486705,"twenty":-6.948093,"median":-2.165169,"eighty":-1.032556,"marketCap":57630994},{"date":"2025-04-25","current":-0.50401,"twenty":-6.778585,"median":-2.119667,"eighty":-1.025324,"marketCap":59680096},{"date":"2025-05-02","current":-0.454061,"twenty":-6.419499,"median":-1.993022,"eighty":-1.012661,"marketCap":53765569},{"date":"2025-05-09","current":-0.45186,"twenty":-6.353202,"median":-1.942322,"eighty":-0.992001,"marketCap":53504992},{"date":"2025-05-16","current":-0.966785,"twenty":-6.271738,"median":-1.899377,"eighty":-0.986031,"marketCap":57263847},{"date":"2025-05-23","current":-0.968819,"twenty":-5.993063,"median":-1.858076,"eighty":-0.967192,"marketCap":57384330},{"date":"2025-05-30","current":-0.915351,"twenty":-5.92365,"median":-1.855328,"eighty":-0.961053,"marketCap":54217349},{"date":"2025-06-06","current":-0.908958,"twenty":-5.896087,"median":-1.835309,"eighty":-0.938951,"marketCap":53838688},{"date":"2025-06-13","current":-1.103071,"twenty":-5.882367,"median":-1.82118,"eighty":-0.938951,"marketCap":65336208},{"date":"2025-06-20","current":-0.997878,"twenty":-5.854145,"median":-1.804107,"eighty":-0.947502,"marketCap":59105516},{"date":"2025-06-27","current":-1.014441,"twenty":-5.758636,"median":-1.779501,"eighty":-0.950271,"marketCap":60086592},{"date":"2025-07-03","current":-0.839508,"twenty":-5.726801,"median":-1.752084,"eighty":-0.936731,"marketCap":49725054},{"date":"2025-07-11","current":-0.863626,"twenty":-5.715074,"median":-1.714941,"eighty":-0.921965,"marketCap":51153638},{"date":"2025-07-18","current":-0.915642,"twenty":-5.677931,"median":-1.687388,"eighty":-0.915526,"marketCap":54234561},{"date":"2025-07-25","current":-1.26944,"twenty":-5.626331,"median":-1.669068,"eighty":-0.915526,"marketCap":75190470},{"date":"2025-08-01","current":-0.996136,"twenty":-5.594214,"median":-1.619916,"eighty":-0.916862,"marketCap":59002350}],"updateTime":1754155813899}}}